Dave
TS Founding Member
Wegovy is a GLP-1 agonist only, this causes the reduced appetite as a side effect. Mounjaro is a GLP-1 agonist and GIP, GIP also impacts appetite but also balances insulin better (insulin spiking is known to instigate fat storage and hunger.
One thing I would say for those worrying is the list price of a drug is rarely the price paid by distributors, they can negotiate discounts to the list price. It’s almost certainly going to increase in price but this is a PR exercise to please the orange dictator in America.
Eli Lilly know the private prescription market in the UK won’t tolerate a huge price increase as we are not an insurance based health economy (it’s complicated but in Australia or other countries with insurance based systems you would co-pay with your insurer for something like this so your out of pocket cost isn’t the full drug price). Small downside of our tax based universal healthcare system is new drugs like this take longer to come to widespread use, but before you rush to wanting insurance based healthcare overall your costs would go up massively).
One thing I would say for those worrying is the list price of a drug is rarely the price paid by distributors, they can negotiate discounts to the list price. It’s almost certainly going to increase in price but this is a PR exercise to please the orange dictator in America.
Eli Lilly know the private prescription market in the UK won’t tolerate a huge price increase as we are not an insurance based health economy (it’s complicated but in Australia or other countries with insurance based systems you would co-pay with your insurer for something like this so your out of pocket cost isn’t the full drug price). Small downside of our tax based universal healthcare system is new drugs like this take longer to come to widespread use, but before you rush to wanting insurance based healthcare overall your costs would go up massively).